> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Advisory Panel to Review Bayer Drug
- URL: https://www.fdaweb.com/advisory-panel-to-review-bayer-drug/
- Published: 2017-09-29T12:00:00.000Z
- Updated: 2026-09-14T22:53:18.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139743

*Federal Register* notice: FDA has announced an 11/16 Antimicrobial Drugs Advisory Committee meeting that will review a Bayer NDA for ciprofloxacin inhalation powder, indicated for reducing exacerbations in non-cystic fibrosis bronchiectasis adult patients with respiratory bacterial pathogens. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-09-29/pdf/2017-20949.pdf?ref=fdaweb.com).